Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'ivacaftor vx 770'

Search results for: 'ivacaftor vx 770'

Items 11-20 of 21

Page
per page
  1. CEP-18770
    A4009 CEP-18770
     1 Citation
    Summary: Proteasome inhibitor
      insoluble in H2O; ≥16.75 mg/mL
  2. JNJ-7706621
    A4115 JNJ-7706621
     1 Citation
    Target: Cyclin-Dependent Kinases|Aurora Kinases
    Summary: Potent CDK/Aurora kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.7 mg/mL
  3. A 77-01
    A3132 A 77-01
    Summary: Potent ALK5 inhibitor
      insoluble in H2O; ≥14.3 mg/mL
  4. STL127705
    BA2757 STL127705
    Summary: STL127705 is a potent inhibitor of Ku70/80 heterodimeric proteins.
  5. PXL770
    BA4638 PXL770
    Summary: PXL770 is a direct activator.
  6. AMG7703
    BA5328 AMG7703
    Summary: AMG7703 is a selective variant agonist of FFA2, a receptor for short-chain fatty acids (SCFA), acetate, and propionate (methylacetic).
  7. A6770
    BA5475 A6770
    Summary: A6770 is an orally effective inhibitor of sphingosine 1-phosphate (S1P) cleavage enzyme.
  8. SNT-207707
    BA5542 SNT-207707
    Summary: SNT-207707 is a potent, selective, orally active melanocortin receptor antagonist.
  9. BMS-770767
    BA7075 BMS-770767
    Summary: BMS-770767 is an 11β-hydroxysteroid dehydrogenase 1 inhibitor for type 2 diabetes.
  10. A-770041
    BA9013 A-770041
    Summary: A-770041 is a selective, orally active inhibitor of the family of...

Items 11-20 of 21

Page
per page